Naltrexone in the Treatment of Pyromania

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Pyromania

In brief

The proposed study will consist of 8 weeks of treatment with either naltrexone or placebo in 10 subjects with pyromania.

Key facts

Study ID

NCT00467454

Run by

University of Minnesota

People needed

0

Starts

2007-06-01

Expected to finish

2010-04-01

Last updated by the study team

2011-12-14

Who can join

Age: 16 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• men and women age 16-75;
• current DSM-IV pyromania

You may not qualify if…

• unstable medical illness or clinically significant abnormalities on prestudy laboratory tests or physical examination;
• history of seizures;
• myocardial infarction within 6 months;
• current pregnancy or lactation, or inadequate contraception in women of childbearing potential;
• clinically significant suicidality;
• current or recent (past 3 months) DSM-IV substance abuse or dependence;
• illegal substance within 2 weeks of study initiation;
• initiation of psychotherapy or behavior therapy from a mental health professional within 3 months prior to study baseline;
• initiation of a psychotropic medication within 2 months prior to study inclusion;
• previous treatment with naltrexone; and
• treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.